Baltimore, MD, United States of America

Panos Zanos

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Panos Zanos: Innovator in Hydroxynorketamine Synthesis

Introduction

Panos Zanos is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmacology, particularly in the synthesis of hydroxynorketamine compounds. With a total of 3 patents to his name, Zanos continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Zanos's latest patents focus on the crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine. The disclosures provide methods for synthesizing free base forms of these compounds. One embodiment includes the preparation of (R)-norketamine via chiral resolution from racemic norketamine using L-pyroglutamic acid. Additionally, the disclosures detail the crystal forms of the corresponding hydrochloride salts of (2R,6R)-hydroxynorketamine and (2S,6S)-hydroxynorketamine.

Career Highlights

Throughout his career, Zanos has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University System of Maryland. His work has significantly impacted the field of medicinal chemistry and pharmacology.

Collaborations

Zanos has collaborated with esteemed colleagues such as Craig J. Thomas and Carlos A. Zarate. These partnerships have further enhanced his research and development efforts in the synthesis of innovative compounds.

Conclusion

Panos Zanos is a distinguished inventor whose work in hydroxynorketamine synthesis has made a lasting impact on pharmacology. His innovative approaches and collaborations continue to advance the field, showcasing the importance of research and development in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…